<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for BPAX</title>
    <link />
    <description>Headlines for BioSante Pharmaceuticals, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>BioSante Pharmaceuticals, Inc. Reports First Quarter Financial Results</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/10/biosante-pharmaceuticals-inc-reports-first-quarter/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 10 May 2013 16:20:35 GMT</pubDate>
    </item>
    <item>
      <title>BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Special Meetings of Stockholders to Consid</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3572046/biosante-pharmaceuticals-and-ani-pharmaceuticals-announce-special-meetings-of-sto.aspx</link>
      <author>Benzinga</author>
      <pubDate>Wed, 08 May 2013 16:06:07 GMT</pubDate>
    </item>
    <item>
      <title>Huge Potential But Tough Entry For Female Sexual Dysfunction Drugs</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1410771-huge-potential-but-tough-entry-for-female-sexual-dysfunction-drugs.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 07 May 2013 16:25:15 GMT</pubDate>
    </item>
    <item>
      <title>Ceregene Reports Disappointing Top-Line Data From Parkinson's Disease Phase 2b Study</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3511840/ceregene-reports-disappointing-top-line-data-from-parkinsons-disease-phase-2b-stu.aspx</link>
      <author>Benzinga</author>
      <pubDate>Fri, 19 Apr 2013 14:01:24 GMT</pubDate>
    </item>
    <item>
      <title>BioSante Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc. Announce New Merger Agreement</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/12/biosante-pharmaceuticals-inc-and-ani-pharmaceutica/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 12 Apr 2013 18:20:14 GMT</pubDate>
    </item>
    <item>
      <title>Reviving The Blockbuster Potential Of Libigel For Biosante And Antares Pharma</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1328041-reviving-the-blockbuster-potential-of-libigel-for-biosante-and-antares-pharma.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 08 Apr 2013 15:53:08 GMT</pubDate>
    </item>
    <item>
      <title>Antares: A Compelling Long-Term Investment</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1292491-antares-a-compelling-long-term-investment.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 21 Mar 2013 12:14:35 GMT</pubDate>
    </item>
    <item>
      <title>BioSante Pharmaceuticals, Inc. Sends Letter Urging Stockholders to Vote “FOR” Proposed Merger with A</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/19/biosante-pharmaceuticals-inc-sends-letter-urging-s/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 19 Mar 2013 09:34:12 GMT</pubDate>
    </item>
    <item>
      <title>BioSante Pharma Sends Letter to Holders, Urges Vote for Proposed Deal with ANI Pharma</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3428192/biosante-pharma-sends-letter-to-holders-urges-vote-for-proposed-deal-with-ani-pha.aspx</link>
      <author>Benzinga</author>
      <pubDate>Tue, 19 Mar 2013 09:02:14 GMT</pubDate>
    </item>
    <item>
      <title>BioSante Pharmaceuticals Announces Adjournment of Its Stockholders Meeting Until April 12, 2013</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/15/biosante-pharmaceuticals-announces-adjournment-of-/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 15 Mar 2013 16:56:24 GMT</pubDate>
    </item>
    <item>
      <title>Ceregene Completes Enrollment Of CERE-110 Phase 2 Trial for Alzheimer's Disease</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3412049/ceregene-completes-enrollment-of-cere-110-phase-2-trial-for-alzheimers-disease.aspx</link>
      <author>Benzinga</author>
      <pubDate>Wed, 13 Mar 2013 07:12:54 GMT</pubDate>
    </item>
    <item>
      <title>Glass, Lewis &amp; Co., LLC Recommends Vote “FOR” BioSante/ANI Merger</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/04/glass-lewis-co-llc-recommends-vote-for-biosanteani/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 04 Mar 2013 09:35:34 GMT</pubDate>
    </item>
    <item>
      <title>BioSante Pharmaceuticals Provides Merger Update and Reports 2012 Financial Results</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/01/biosante-pharmaceuticals-provides-merger-update-an/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 01 Mar 2013 09:21:44 GMT</pubDate>
    </item>
    <item>
      <title>BioSante Pharma Offers Merger Update: Says Significant Number of Shares Not Yet Voted</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3381362/biosante-pharma-offers-merger-update-says-significant-number-of-shares-not-yet-vo.aspx</link>
      <author>Benzinga</author>
      <pubDate>Fri, 01 Mar 2013 09:17:20 GMT</pubDate>
    </item>
    <item>
      <title>Leading Independent Proxy Advisory Firm ISS Joins Egan-Jones in Recommending “FOR” BioSante/ANI Merg</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/26/leading-independent-proxy-advisory-firm-iss-joins-/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 26 Feb 2013 09:21:25 GMT</pubDate>
    </item>
    <item>
      <title>ISS Recommends BioSante Merger with ANI</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3367419/iss-recommends-biosante-merger-with-ani.aspx</link>
      <author>Benzinga</author>
      <pubDate>Tue, 26 Feb 2013 09:02:02 GMT</pubDate>
    </item>
    <item>
      <title>Following Crashing Biotechs - 5 Bargains To Consider</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1223791-following-crashing-biotechs-5-bargains-to-consider.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 26 Feb 2013 06:17:05 GMT</pubDate>
    </item>
    <item>
      <title>Egan-Jones Proxy Services Recommends Stockholders Vote “FOR” BioSante and ANI Merger</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/19/egan-jones-proxy-services-recommends-stockholders-/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 19 Feb 2013 09:51:26 GMT</pubDate>
    </item>
    <item>
      <title>4 Speculative Biotech Stocks To Consider</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1146601-4-speculative-biotech-stocks-to-consider.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 31 Jan 2013 10:48:17 GMT</pubDate>
    </item>
    <item>
      <title>C'est La Vie, AbbVie!</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/01/30/cest-la-vie-abbvie/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 30 Jan 2013 14:39:00 GMT</pubDate>
    </item>
  </channel>
</rss>
